CN102302642A - Medicament for treating chloasma and preparation method thereof - Google Patents
Medicament for treating chloasma and preparation method thereof Download PDFInfo
- Publication number
- CN102302642A CN102302642A CN201110273511A CN201110273511A CN102302642A CN 102302642 A CN102302642 A CN 102302642A CN 201110273511 A CN201110273511 A CN 201110273511A CN 201110273511 A CN201110273511 A CN 201110273511A CN 102302642 A CN102302642 A CN 102302642A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- chloasma
- processed
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating chloasma. The medicament is prepared from safranine, bupleurum, largehead atractylodes rhizome, Chinese angelica, white paeony root, root of red-rooted salvia, tuckahoe, green tangerine leaf, prepared nutgrass galingale rhizome and mint which serve as raw materials. The medicament can be prepared into various medicines which are used clinically. In a formula, the medicaments are reasonable in compatibility, have the effects of tonifying middle-jiao and qi and soothing liver and promoting blood circulation under the synergetic treatment action, and are suitable for chloasma symptoms caused by various reasons. Clinical test results prove that the medicament has an obvious effect, does not have toxic or side effect, and is safe and reliable in clinical application.
Description
Technical field
The present invention relates to a kind of medicine of treating chloasma, specially referring to a kind of is the method for preparing that the medicine of the treatment chloasma of feedstock production the invention still further relates to this medicine with the Chinese herbal medicine.
Background technology
At present, chloasma is world's difficult miscellaneous diseases, seriously perplexs hundreds of millions women's questions of one's reputation.With waist and shank pain is the traumatology disease of cardinal symptom.Chloasma is also referred to as chloasma hepaticum and butterfly spot, is a kind of symptom of facial melanosis, is the pigmentation spots that occurs in face.Mainly because of the female incretion imbalance, stress is big for chloasma, lacks the stimulation of vitamin and external chemicals in various diseases (hepatic and kidney function obstacle, gynaecopathia, diabetes) etc. and the body and causes.Long-term chloasma can cause tremendous influence to health, should cause enough attention.
The at present Western medicine and the operative treatment of treatment chloasma, taking for a long time of Western medicine makes the people strengthen the dependency to medicine easily, and the organ of taking for a long time the intestines and stomach of human body has very big side effect.Operative treatment is devoted to the elimination of surface symptoms, and is difficult to eliminate the disease origin, and the traditional Chinese medical science then has unique curative effect to this disease.
Summary of the invention
The present invention aims to provide that a kind of therapeutic effect is good, cost is low, the medicine of the medicine of the treatment chloasma of non-evident effect and preparation method thereof.
The method for preparing that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be processed by following quality proportion raw material:
Stigma Croci 15-20 part, Radix Bupleuri 15-20 part, Rhizoma Atractylodis Macrocephalae 8-12 part, Radix Angelicae Sinensis 15-20 part, Radix Paeoniae Alba 8-12 part, Radix Salviae Miltiorrhizae 14-18 part, Poria 12-17 part, blue or green Folium Citri tangerinae 5-8 part, Rhizoma Cyperi (processed) 8-12 part, Herba Menthae 4-8 part.
The further quality proportioning of medicine each component of the present invention is:
18 parts of Stigma Crocis, 16 parts of Radix Bupleuri, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 16 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, 16 parts of Radix Salviae Miltiorrhizaes, 15 parts in Poria, 6 parts of blue or green Folium Citri tangerinae, 10 parts of Rhizoma Cyperi (processed), 5 parts of Herba Menthaes.
Medicine of the present invention can be processed said dosage form on any pharmaceutics, is preferred dosage form here with the capsule.
The concrete method for preparing of medicine of the present invention is following:
With above-mentioned various medicines according to described ratio of weight and number mix homogeneously after; Decocte with water 3 times; Each 0.5～1 hour; Merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25～1.3 thick paste; After 50～60 ℃ of dryings; Be crushed to 100～120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Motherland's medical science thinks that liver is lost bar and reaches, mechanism of qi pent-up, and strongly fragrant fire-transformation of a specified duration, the cloudy blood of burning, hematogenous blockage can cause face qi-blood disharmony; Deficiency-weakness of spleen-QI, the fortuneization mistake is strong, and it is little to change spermatogenesis, and then QI and blood can not be moistened in face; Insufficiency of kidney-YANG, pathological changes such as deficiency of kidney-essence all can cause face generation chloasma.All medicine reasonable compatibilities in the prescription of the present invention, the collaborative treatment can invigorating the spleen and replenishing QI, and soothing the liver promoting the circulation of blood is applicable to the chloasma symptom that multiple reason causes.
During treatment, this medicine was taken for three times morning, noon, the late branch.
Use clinical drug treatment chloasma patient 300 examples of the present invention and suffer from, symptom complete obiteration person 264 examples, obvious improver's 33 examples of symptom, total effective rate reaches family 99%.Clinical test results proves that effect of drugs of the present invention is obvious, definite, and has no side effect, and clinical practice is safe and reliable.
The specific embodiment
Below in conjunction with embodiment the present invention is done further explain, but do not constitute any restriction of the present invention.
Embodiment 1
Prepare raw material according to following weight:
Stigma Croci 16kg, Radix Bupleuri 19kg, Rhizoma Atractylodis Macrocephalae 9kg, Radix Angelicae Sinensis 16kg, Radix Paeoniae Alba 11kg, Radix Salviae Miltiorrhizae 17kg, Poria 13kg, blue or green Folium Citri tangerinae 6 kg, Rhizoma Cyperi (processed) 9kg, Herba Menthae 5 kg.
With above-mentioned various medicines according to described ratio of weight and number mix homogeneously after; Decocte with water 3 times; Each 0.5～1 hour; Merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25～1.3 thick paste; After 50～60 ℃ of dryings; Be crushed to 100～120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Embodiment 2
Prepare raw material according to following weight:
Stigma Croci 19 kg, Radix Bupleuri 16 kg, Rhizoma Atractylodis Macrocephalae 10kg, Radix Angelicae Sinensis 19 kg, 9 parts of the Radix Paeoniae Albas, Radix Salviae Miltiorrhizae 15kg, Poria 16kg, blue or green Folium Citri tangerinae 5kg, Rhizoma Cyperi (processed) 11 kg, Herba Menthae 7 kg.
With above-mentioned various medicines according to described ratio of weight and number mix homogeneously after; Decocte with water 3 times; Each 0.5～1 hour; Merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25～1.3 thick paste; After 50～60 ℃ of dryings; Be crushed to 100～120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Claims (4)
1. medicine of treating chloasma is characterized in that said medicine is to be processed by following quality proportion raw material:
Stigma Croci 15-20 part, Radix Bupleuri 15-20 part, Rhizoma Atractylodis Macrocephalae 8-12 part, Radix Angelicae Sinensis 15-20 part, Radix Paeoniae Alba 8-12 part, Radix Salviae Miltiorrhizae 14-18 part, Poria 12-17 part, blue or green Folium Citri tangerinae 5-8 part, Rhizoma Cyperi (processed) 8-12 part, Herba Menthae 4-8 part.
2. the medicine of treatment chloasma according to claim 1 is characterized in that said medicine is to be processed by following quality proportion raw material:
18 parts of Stigma Crocis, 16 parts of Radix Bupleuri, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 16 parts of Radix Angelicae Sinensis, 10 parts of the Radix Paeoniae Albas, 16 parts of Radix Salviae Miltiorrhizaes, 15 parts in Poria, 6 parts of blue or green Folium Citri tangerinae, 10 parts of Rhizoma Cyperi (processed), 5 parts of Herba Menthaes.
3. the medicine of treatment chloasma according to claim 1 and 2 is characterized in that said medicine is processed capsule.
4. the method for preparing of the medicine of chloasma is treated in the described treatment of claim 3; Be with above-mentioned various medicines according to described ratio of weight and number mix homogeneously after; Decocte with water 3 times each 0.5～1 hour, merges 3 times decocting liquid; Filter; Be condensed into 60 ℃ of relative densities and be 1.25～1.3 thick paste, after 50～60 ℃ of dryings, be crushed to 100～120 purpose medicated powder; In incapsulating, sterilization makes the capsule product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110273511A CN102302642A (en) | 2011-09-15 | 2011-09-15 | Medicament for treating chloasma and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110273511A CN102302642A (en) | 2011-09-15 | 2011-09-15 | Medicament for treating chloasma and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102302642A true CN102302642A (en) | 2012-01-04 |
Family
ID=45376624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110273511A Pending CN102302642A (en) | 2011-09-15 | 2011-09-15 | Medicament for treating chloasma and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102302642A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784098A (en) * | 2015-04-01 | 2015-07-22 | 广西大学 | Speckle-diluting and whitening glycyrrhiza glabra mask powder |
| CN106421697A (en) * | 2016-10-14 | 2017-02-22 | 亳州市庆聚药业销售有限公司 | Traditional Chinese medicine decoction capable of removing chloasma |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102139034A (en) * | 2011-04-07 | 2011-08-03 | 王勇勤 | Medicament for treating chloasma |
-
2011
- 2011-09-15 CN CN201110273511A patent/CN102302642A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102139034A (en) * | 2011-04-07 | 2011-08-03 | 王勇勤 | Medicament for treating chloasma |
Non-Patent Citations (1)
| Title |
|---|
| 南京中医药大学 编著: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784098A (en) * | 2015-04-01 | 2015-07-22 | 广西大学 | Speckle-diluting and whitening glycyrrhiza glabra mask powder |
| CN106421697A (en) * | 2016-10-14 | 2017-02-22 | 亳州市庆聚药业销售有限公司 | Traditional Chinese medicine decoction capable of removing chloasma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN101708302A (en) | Chinese medicinal preparation for treating diabetes and preparation method thereof | |
| CN105147847A (en) | Drug composition for benefiting qi and nourishing blood | |
| CN103386008A (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN104547486A (en) | Traditional Chinese medicine preparation for treating anemia and qi-deficiency weakness and preparation process for traditional Chinese medicine preparation | |
| CN102988672A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN102552454A (en) | Traditional Chinese medicine for curing diabetic foot | |
| CN101843694A (en) | Chinese medicament for treating chronic hepatitis | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN105362904A (en) | Qi tonifying and blood nourishing traditional Chinese medicinal pill and preparation method thereof | |
| CN102302642A (en) | Medicament for treating chloasma and preparation method thereof | |
| CN101912540A (en) | Medicament for treating cerebral infarction | |
| CN102078559A (en) | Chinese medicinal composition with functions of tonifying kidney and strengthening brain | |
| CN104162088A (en) | Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof | |
| CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
| CN102048930A (en) | Formula of traditional Chinese medicine for treating chronic gastritis | |
| CN103301264B (en) | Medicine for treating ankylosing spondylitis | |
| CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
| CN103182037A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN103272029A (en) | Traditional Chinese medicine formula for curing hypertension | |
| CN101966304A (en) | Medicament for freeing network vessels and activating blood and preparation method thereof | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN102370838B (en) | Kidney-invigorating and tendon-reinforcing double-phase capsule | |
| CN105497783A (en) | Application of traditional Chinese medicine preparation to preparing drug for treating qi stagnation and blood stasis type chloasma | |
| CN104547865A (en) | Application of traditional Chinese medicine preparation in preparing medicine for treating senile dementia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120104 |